View Press Releases
-
Argonaut Manufacturing Services Set to Expand Drug Product Fill/Finish Capabilities with Significant Capital Investment
Argonaut Manufacturing Services Set to Expand Drug Product Fill/Finish Capabilities with Significant Capital Investment
Jan 9, 2023
-
CSafe Further Expands Its Digital Ecosystem with Enhancement of CSafe Connect and Launch of TracSafe Data Logger Suite
CSafe Connect enables a truly connected supply chain by bringing together product ordering, shipment analytics and customer support under a single login
Jan 9, 2023
-
Phastar enhances Data Visualization and Analytics solution through acquisition of S-Cubed ApS, adds capability in Denmark
Phastar enhances Data Visualization and Analytics solution through acquisition of S-Cubed ApS, adds capability in Denmark. London, UK and Durham, NC – January 10, 2023 – Phastar announced today the acquisition of S-Cubed ApS, a specialist biometrics and data visualization company. The deal takes the PHASTAR group to around 550 people worldwide and strengthens the company's position in the Nordic region.
Jan 9, 2023
-
SANGUINE BIOSCIENCES PARTNERS WITH BROADOAK CAPITAL PARTNERS TO ACCELERATE LAUNCH OF NEW PRODUCTS AND SERVICES IN SUPPORT OF CELL & GENE THERAPY MARKETS
Investment will support ongoing partnerships with apheresis clinics, expansion of laboratory services, enhancement of patient data aggregation, and amplification of Sanguine’s network of 60,000+ research-ready patient donor network.
Jan 8, 2023
-
Quanticate makes key appointment to bolster leadership team
-
ODAIA Appoints Former WebMD Exec Dr. Eric Trépanier as Chief Commercial Officer
-
OncoDxRx’s Breakthrough Technology Advances Gene-Drug Matching
OncoDxRx's PGA technology is the world-first test that enables gene-drug matching for optimal treatment regimen from hundreds of anti-cancer drugs based on patients’ own gene expression profiles
Jan 7, 2023
-
Battelle, AmplifyBio, Andelyn Biosciences Win Research Contract for National Institute of Neurological Disorders and Stroke
Battelle, AmplifyBio, Andelyn Biosciences Win Research Contract for National Institute of Neurological Disorders and Stroke
Jan 5, 2023
-
Wesley Vestal Named CAI's Chief People Officer; Joins Company Leadership Team
Wesley Vestal Named CAI's Chief People Officer; Joins Company Leadership Team
Jan 1, 2023
-
Molecular Devices and Advanced Solutions Life Sciences collaborate to develop 3D Biology Automation Technologies for Drug Discovery
Molecular Devices, a leader in high-performance life sciences solutions, on Wednesday announced a new collaboration with Advanced Solutions, a biofabrication and life sciences robotics company. This new collaboration takes the form of a turnkey solution that systematically bioprints organoids in a fully-automated enclosure, with award-winning high-content imaging capabilities that inform the modeling and screening process for increased precision--enabling the industry to grow, screen, and analyze high-quality, viable, 3D cell cultures at scale.
Jan 3, 2023
-
CD BioSciences Introduces Various Solutions for Autophagic Cell Death Studies
CD BioSciences recently launched another comprehensive panel of research solutions for autophagic cell death studies.
Jan 4, 2023
-
Creative Diagnostics Introduces New Hemagglutination Inhibition Assay Services
Creative Diagnostics recently introduced Hemagglutination Inhibition Assay services to determine relative concentrations of viruses, bacteria, or antibodies.
Jan 4, 2023
-
STEMart Introduces API Impurity Identification Services for Medical Devices
STEMart has recently introduced API Impurity Identification services for global clients.
Jan 4, 2023
-
OncoDxRx Honing Unique Transformative Technologies for Personalized Diagnostic Capability
OncoDxRx's unique liquid biopsy technologies create another dimension beyond traditional diagnostic capability.
Jan 3, 2023
-
Abzena hires Matthew Stober to lead the company through the next phase of global growth
Matthew Stober hired as CEO and joins Abzena Board. Abzena continues growth as the leading provider of development and manufacturing services for Antibody Drug Conjugate (ADC) and complex biologics. Board enhanced with CDMO and Biologics industry luminaries to support future growth.
Jan 3, 2023
-
Verana Health and Sight Sciences Collaborate on Glaucoma Research Using Curated Real-World Data from the IRIS Registry
Verana Health and Sight Sciences Collaborate on Glaucoma Research Using Curated Real-World Data from the IRIS Registry
Jan 3, 2023
-
Blue Spark Technologies to Highlight Continuous Patient Temperature Monitoring at CES 2023
Blue Spark Technologies, Inc., a leader in wearable remote patient monitoring solutions, will showcase TempTraq® at the 2023 Consumer Electronics Show (CES) at the Las Vegas Convention Center January 5-8.
Jan 2, 2023
-
OncoDxRx Demonstrating the Power of Its One-Of-A-Kind RNA Technologies to Go Beyond Diagnostics
OncoDxRx will thus secure its forefront position to deal with cancer patients in all stages, whether in the context of cancer screening and prevention or in the context of treatment selection, recurrence monitoring or drug discovery.
Dec 31, 2022
-
Creative Biogene Has Established More Than 50 Engineered Zebrafish Models to Support Human Cancer Research
-
Microbiosci Develops Microbial Cell Line Generation for Therapeutics and Diagnostic Applications